The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction

Summary

300 STIMI patients with LV systolic dysfunction will be divided into two equal groups (Group I (Study arm, n=150); will receive dapagliflozin plus conventional therapy and group (II) Control arm (n=150); will receive conventional therapy only to detect an improvement in the LVEF by ≥ 5

Timeline

Start

2021-12

Primary completion

2022-06

Completion

2022-09

Drugs

Indications